Source: Life Care News

Arcutis: Arcutis to Present at the TD Cowen 45th Annual Health Care Conference

WESTLAKE VILLAGE, Calif., Feb. 18, 2025 (GLOBE NEWSWIRE) - Arcutis Biotherapeutics, Inc. (Nasdaq: ARQT), a commercial-stage biopharmaceutical company focused on developing meaningful innovations in immuno-dermatology, today announced that Arcutis management will participate in the TD Cowen 45th Annual Health Care Conference, taking place March 3-5, 2025. Details for the company's participation are as follows: Fireside Chat Date: [...]

Read full article »
Annual Revenue
$100-500M
Employees
250-500
Frank Watanabe's photo - President & CEO of Arcutis

President & CEO

Frank Watanabe

CEO Approval Rating

86/100

Read more